FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application from Sandoz Inc for hydroxyzine pamoate (ANDA 087479), authorizing the generic product under the approved labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Pruritus

Drugs mentioned

• Hydroxyzine pamoate (Hydroxyzine pamoate)

Snippet

SUPPL AP for HYDROXYZINE PAMOATE (HYDROXYZINE PAMOATE)